Discordance between frequency of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon-producing CD4+ T cells and HIV-1-specific lymphoproliferation in HIV-1-infected subjects with active viral replication

Journal of Virology

Volumn 76, Issue 12, 2002, Pages 5925-5936

  Palmer, B E ^a   Boritz, E ^a   Blyveis, N ^a   Wilson, C C ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; GAMMA INTERFERON;

ADULT; ARTICLE; CLINICAL ARTICLE; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HELPER CELL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE; LYMPHOCYTE PROLIFERATION; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS LOAD; VIRUS REPLICATION;

ADULT; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4-POSITIVE T-LYMPHOCYTES; HIV CORE PROTEIN P24; HIV INFECTIONS; HIV-1; HUMANS; INTERFERON TYPE II; LYMPHOCYTE ACTIVATION; RNA, VIRAL; VIRAL LOAD; VIRUS REPLICATION;

EID: 0036114014     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.76.12.5925-5936.2002     Document Type: Article

References (41)

1. Maximum suppression of HIV replication leads to the restoration of HIV-specific responses in early HIV disease
2. Improvement in cell-mediated immune function during potent anti-human immunodeficiency virus therapy with ritonavir plus saquinavir
3. Progressive human immunodeficiency virus-specific immune recovery with prolonged viral suppression
4. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease
5. Antigenic peptides recognized by T lymphocytes from AIDS viral envelope-immune humans
6. Proliferative responses to human immunodeficiency virus type 1 (HIV-1) antigens in HIV- 1-infected patients with immune reconstitution
7. CD28 costimulation and T lymphocyte proliferative responses in HIV-1 infection
8. Downregulation of CD28 surface antigen on CD4+ and CD8+ T lymohcytes during HIV-1 infection
9. CD40 ligand and IFN-gamma synergistically restore IL-12 production in HIV-infected patients
10. Antigen-stimulated apoptotic T-cell death in HIV infection is selective for CD4+ T cells, modulated by cytokines and effected by lymphotoxin
11. Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus- seropositive patients. Independence of CD4+ cell numbers and clinical staging
12. Specific Th1 cytokine down-regulation associated with primary clinically derived human immunodeficiency virus type 1 Nef gene-induced expression
13. The role of HIV 1 Nef in T-cell activation: Nef impairs induction of Th1 cytokines and interacts with the Src family tyrosine kinase Lck
14. Immune reconstitution in the first year of potent antiretroviral therapy and its relationship to virologic response
15. Selective CD4+ T cell deletion after specific activation in HIV-infected individuals; protection by anti-CD28 monoclonal antibodies
16. Apoptotic cell death in the pathogenesis of infectious diseases
17. CD40 ligand trimer and IL-12 enhance peripheral blood mononuclear cells and CD4+ T cell proliferation and production of IFN- gamma in response to p24 antigen in HIV-infected individuals: Potential contribution of anergy to HIV-specific unresponsiveness
18. Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals
19. Direct measurement of CD4+ and CD8+ T-cell responses to CMV in HIV-1-infected subjects
20. Lymphocyte proliferative responses to human immunodeficiency virus antigens in vitro
21. Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome. Evidence for a selective defect in soluble antigen recognition
22. Immunologic responses associated with 12 weeks of combination antiretroviral therapy consisting of zidovudine, lamivudine, and ritonavir: Results of AIDS Clinical Trials Group Protocol 315
23. Antiviral effect and ex vivo CD4+ T cell proliferation in HIV-positive patients as a result of CD28 costimulation
24. Pathogenesis of human immunodeficiency virus infection
25. + cytotoxic T-cell responses during chronic viral infection
26. + T cell proliferation
27. Programmed death of T cells in HIV-1 infection
28. Programmed death of T cells in human immunodeficiency virus infection. No correlation with progression to disease
29. HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression
30. Lack of T-cell proliferative response to HIV-1 antigens after 1 year of highly active antiretroviral treatment in early HIV-1 disease. Immunology Study Group of Spanish EARTH-1 study
31. Lymphoproliferative response to HIV type 1 p24 in long-term survivors of HIV type 1 infection is predictive of persistent AIDS-free infection
32. Antigen-specific T-lymphocyte proliferative responses during highly active antiretroviral therapy (HAART) of HIV-1 infection
33. Prolonged suppression of human immunodeficiency virus type 1 (HIV-1) viremia in persons with advanced disease results in enhancement of CD4 T cell reactivity to microbial antigens but not to HIV-1 antigens
34. Immune control of HIV-1 after early treatment of acute infection
35. Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia
36. HIV-induced immuopathogenesis
37. Early T-helper cell defects in HIV infection
38. Differential expression of interleukin-2 and gamma interferon in human immunodeficiency virus disease
39. Characteristics of the specific cell-mediated immune response in human immunodeficiency virus infection
40. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor
41. Loss of CD4+ T cell proliferative ability but not loss of human immunodeficiency virus type 1 specificity equates with progression to disease